Target intelligence / Profile preview

Nucleophilic cellular proteins and peptides

Molecular classification
Other, Proteins, Peptides
01

Overview

Nucleophilic cellular proteins and peptides represent a broad chemical class of biological molecules containing electron-rich functional groups, such as the sulfhydryl group of cysteine, the amino group of lysine, and the imidazole group of histidine (PubChem, 2024). These nucleophilic sites are essential for the physiological function of many enzymes, where they often serve as catalytic residues, and for maintaining cellular redox balance through molecules like glutathione (NIH, 2023). In pharmacology, this category is not a single discrete target but rather a collective site of action for electrophilic drugs, such as nitrogen mustards and platinum-based antineoplastics, which form stable covalent bonds with these groups to disrupt cellular processes (StatPearls, 2023). While these interactions are leveraged to inhibit rapid cell division in cancer, the inherent lack of specificity across the proteome leads to significant off-target effects and safety concerns, including secondary malignancies and systemic toxicity (PubMed, 2022). Consequently, this term is typically used to describe a general mechanism of drug-protein interaction or toxicological reactivity rather than a specific therapeutic target for drug development.

Other names
Cellular nucleophilesNucleophilic residuesProtein thiolsProtein aminesNucleophilic targetsEndogenous nucleophiles
02

Mechanism of action

Covalent modification of nucleophilic functional groups (e.g., sulfhydryl, amino, hydroxyl, or imidazole groups) through alkylation, acylation, or coordination by electrophilic drugs or reactive metabolites.

03

Biological functions

Enzymatic catalysisRedox homeostasisStructural maintenanceSignal transductionMetabolic regulation
04

Disease associations

CancerToxicityOxidative stressHypersensitivity reactions
05

Safety considerations

Non-specific systemic toxicityMutagenicityCarcinogenicityImmunogenicity (hapten-mediated hypersensitivity)Organ-specific damage (e.g., hepatotoxicity, nephrotoxicity)Bone marrow suppression
06

Interacting drugs

Cyclophosphamide

9 more in the full profile.

07

Biomarkers

Protein-drug adductsGlutathione (GSH) depletion levelsCysteine-rich protein expressionHemoglobin adducts

Beyond the preview

Go deeper on Nucleophilic cellular proteins and peptides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophilic cellular proteins and peptides.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call